QDRO Acquisition Corp. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2026. Filed November 13, 2026. The unaudited interim statements cover a Cayman Islands blank-check company formed to pursue a business combination; it has not begun operating activities or generated revenue.
Financial position and performance
| Metric | Period or date | Amount |
|---|---|---|
| Operating revenue | Three and nine months ended September 30, 2026 | None |
| General and administrative costs | Three months | $267,793 |
| General and administrative costs | Nine months | $1,132,620 |
| Trust-account interest income | Three months | $1,830,474 |
| Trust-account interest income | Nine months | $3,640,271 |
| Net income | Three months | $1,562,681, or $0.06 per Class A and Class B share |
| Net income | Nine months | $2,507,651, or $0.14 per Class A and Class B share |
| Cash and marketable securities in trust | September 30, 2026 | $203,640,271 |
| Cash outside trust | September 30, 2026 | $171,403 |
| Working capital | September 30, 2026 | $279,571 surplus |
| Total liabilities | September 30, 2026 | $8,571,291 |
| Shareholders’ deficit | September 30, 2026 | $8,100,888 |
| Operating cash flow | Nine months | $(1,149,688) |
Net income principally reflects interest earned on trust investments, not business operations. Margins are not meaningful for this pre-combination company. The filing reports no long-term debt or working-capital loans outstanding. Liabilities include an $8 million deferred underwriting fee payable upon a business combination and $411,911 in deferred legal fees, payable regardless of whether a business combination is completed.
Changes versus prior periods
The company completed its IPO on March 30, 2026, selling 20 million units for $200 million and placing $200 million in trust. It also sold 6 million private placement warrants for $6 million. Trust assets grew to $203.64 million, including accumulated interest. The underwriters forfeited their over-allotment option; 750,000 founder shares were consequently forfeited, leaving 5 million Class B shares outstanding. The prior-year comparison is for the period from inception on July 28, 2025 through September 30, 2025, rather than a comparable quarter: that period recorded a $56,101 net loss and no trust assets.
Outlook, risks and notable items
- The company has 18 months from the March 30, 2026 IPO closing—through September 30, 2027—to complete an initial business combination, or it must redeem public shares and liquidate, subject to applicable requirements. No target or transaction is identified in this filing.
- Management says it expects significant continuing acquisition-search costs and intends to complete a business combination within the completion window, but success is uncertain. It states that it lacks liquidity to sustain operations for at least one year after issuance of these financial statements; this, together with the deadline and dependence on a transaction, raises substantial doubt about the company’s ability to continue as a going concern.
- The trust is primarily invested in short-term U.S. Treasury securities. Trust funds are generally restricted until a business combination, redemptions, or specified other permitted uses. Public shares were recorded at a redemption value of $10.18 per share at quarter-end.
- The Sponsor may, but is not obligated to, provide working-capital loans. No such loans were outstanding at September 30, 2026. The Sponsor’s trust-protection indemnity has limitations, and the company says it has not verified the Sponsor’s ability to meet it.
- Management cited geopolitical conflict, trade tensions, sanctions, tariffs, market volatility and other economic disruptions as factors that could hinder the search for or completion of a business combination. It reported no material changes to the IPO prospectus risk factors and no legal proceedings.
- Disclosure controls were assessed as effective at a reasonable assurance level; no material change in internal control over financial reporting was reported. No subsequent event requiring adjustment or disclosure was identified through November 13, 2026.
Important facts for investors to verify
- Whether the company identifies and completes a qualifying business combination before the September 30, 2027 deadline, and whether any extension is proposed.
- Cash available outside the trust and projected costs against the company’s stated liquidity and going-concern concerns.
- Trust balance, permitted withdrawals, redemption terms, and the treatment of deferred underwriting and legal fees in a transaction or liquidation.
- Any proposed financing, working-capital loans, share issuance, redemptions, or resulting dilution to public shareholders.
- The company’s disclosures in subsequent filings about target discussions, transaction contingencies, and changes in risk factors.